Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
第一作者:
Liyun,He
第一单位:
Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
作者:
主题词
成年人(Adult);胆囊炎(Cholecystitis);胆结石(Cholelithiasis);糖尿病, 2型(Diabetes Mellitus, Type 2);女(雌)性(Female);胰高血糖素样肽1(Glucagon-Like Peptide 1);人类(Humans);男(雄)性(Male);中年人(Middle Aged);随机对照试验(主题)(Randomized Controlled Trials as Topic);体重减轻(Weight Loss)
DOI
10.1001/jamainternmed.2022.0338
PMID
35344001
发布时间
2025-01-03
- 浏览2

JAMA internal medicine
2022年182卷5期
513-519页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文